New Indications for Novel Fluoroquinolones: Moxifloxacin in the Treatment of Nosocomial Infections

New Indications for Novel Fluoroquinolones: Moxifloxacin in the Treatment of Nosocomial Infections

Saved in:

Bibliographic Details
Main Authors:	N. V. Beloborodova, D. A. Popov, T. YU. Vostrikova, E. N. Bachinskaya, S. T. Kuznetsova
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/201
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fluoroquinolone-Induced Aortic Injury
by: N. V. Izmozherova, et al.
Published: (2021-07-01)

Nosocomial Infection Program
by: Shirley Paton
Published: (1995-01-01)

Prevention of Nosocomial Respiratory Infections
by: N. A. Karpun, et al.
Published: (2007-06-01)

The use of fluoroquinolones in the treatment of community-acquired pneumonia and their cardiotoxic effects
by: Gamayunov D.Yu., et al.
Published: (2024-12-01)

Nosocomial infections in the departments of orthopedics and traumatology
by: Maksimović Jadranka M., et al.
Published: (2005-01-01)

A New Insight into Nosocomial Infections: a Worldwide Crisis
by: Elham Sheykhsaran1, 2, 3, et al.
Published: (2022-06-01)

Complexation of fluoroquinolones with magnesium ions
by: V. M. Bakhtin, et al.
Published: (2022-10-01)

The prevalence of pediatric nosocomial fungal infections
by: Parisa Badiee, et al.
Published: (2025-07-01)

Clinical Presentations and Nosocomial Infections of Neurolisteriosis
by: Javier Vicente Trejos Pino, et al.
Published: (2025-01-01)

Inhaled Antibiotics in the Treatment of Nosocomial Pneumonia
by: A. N. Kuzovlev, et al.
Published: (2013-12-01)

DEVELOPMENT AND VALIDATION OF MOXIFLOXACIN DETERMINATION IN HUMAN PLASMA BY HPLC-UV METHOD
by: T. N. Komarov, et al.
Published: (2019-01-01)

Safety of Fluoroquinolones: An Update
by: L Mandell, et al.
Published: (2002-01-01)

Role of Mental Disorders in Nosocomial Infections after Hip Fracture Treatment
by: Enrique Guerado, et al.
Published: (2010-01-01)

Moxifloxacin-induced neutropenia in 26-year-old man
by: Tuğba Kula Atik, et al.
Published: (2018-10-01)

The diverse phenotypic and mutational landscape induced by fluoroquinolone treatment
by: Sayed Golam Mohiuddin, et al.
Published: (2025-08-01)

Nosocomial infections caused by bacteria of Enterobacteriacae family in cancer clinic
by: N. V. Dmitrieva, et al.
Published: (2019-02-01)

Nosocomial Infection in Patients with Severe and Critical COVID-19
by: M. V. Bychinin, et al.
Published: (2022-02-01)

NOSOCOMIAL INFECTIONS IN PATIENTS WITH UROLITHIASIS IN THE POSTOPERATIVE PERIOD
by: F. S. Sadulloev
Published: (2015-10-01)

Nosocomial infections in HIV-infected and HIV-uninfected children hospitalised for tuberculosis
by: Ann Robinson, et al.
Published: (2007-07-01)

Engineering Moxifloxacin-Encapsulated Liposome-Enriched Alginate Hydrogel Films
by: Ismail Bal, et al.
Published: (2025-06-01)

Microbiological spectrum of nosocomial infection in patients with infectious spondylitis after sepsis
by: A. A. Vishnevskiy, et al.
Published: (2019-12-01)

Emergence of Novel Fluoroquinolone Resistance Mutations in Mycoplasma bovis, China, 2008–2023
by: Shimei Lan, et al.
Published: (2025-08-01)

Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients.
by: Mohideen S Jawahar, et al.
Published: (2013-01-01)

Light and drugs: the photochemistry of fluoroquinolone antibiotics
by: Elissa Fasani, et al.
Published: (1999-01-01)

Theoretically improved biodegradability of fluoroquinolones in sewage and sludge
by: Yajing Liu, et al.
Published: (2025-09-01)

Emerging trends of nosocomial Citrobacter species surgical wound infection: concern for infection control
by: B Thapa, et al.
Published: (2012-01-01)

Emerging trends of nosocomial Citrobacter species surgical wound infection: concern for infection control
by: B Thapa, et al.
Published: (2012-01-01)

ADEQUATE EMPIRIC THERAPY OF NOSOCOMIAL FUNGAL INFECTIONS IN ONCOLOGICAL PATIENTS IN THE INTENSIVE CARE UNITS
by: S. D. Mitrokhin, et al.
Published: (2020-05-01)

MATHEMATICAL SIMULATION OF NOSOCOMIAL INFECTION SPREAD AND THE ROLE OF NURSINGBASED INTERVENTIONS
by: Sinjit Mukherjee, et al.
Published: (2025-06-01)

Long Term Trends in the Occurrence of Nosocomial Blood Stream Infection
by: Geoffrey Taylor, et al.
Published: (2000-01-01)

Nursing activities in the prevention and control of nosocomial infection in the emergency sector
by: Airana Caroline Laudisio Sales, et al.
Published: (2014-02-01)

Cerebrospinal Fluid Presepsin as a Marker of Nosocomial Infections of Central Nervous System
by: S. A. Abudeyev, et al.
Published: (2019-04-01)

EFFICIENCY OF TRANSPULMONARY THERMODILUTION IN THE OPTIMIZATION OF INTENSIVE TREATMENT IN PATIENTS WITH SEVERE NOSOCOMIAL PNEUMONIA
by: S. N. Avdeykin, et al.
Published: (2015-05-01)

Moxifloxacin Metal Complexes: Synthesis, Characterisation, Antimicrobial and Antidiabetic Activities with Docking Studies
by: Sajjad Ali, et al.
Published: (2023-01-01)

Current prospects of fluoroquinolones: pazufloxacin. A review
by: Olga I. Butranova, et al.
Published: (2025-01-01)

CURRENT ASPECTS OF NOSOCOMIAL LEGIONELLOSIS PROFILAXIS
by: I. S. Tartakovsky, et al.
Published: (2010-06-01)

Studying the relationship of Nosocomial infection to the age, gender and educational level of the patient
by: Shaimaa Abd Mohammed Ali, et al.
Published: (2019-03-01)

Community-Acquired and Nosocomial Pneumonia: Clinical and Morphological Features
by: A. M. Golubev, et al.
Published: (2010-06-01)

Metal chelation approach synergized with surfactant for spectrofluorimetric assay of moxifloxacin with method greenness evaluation
by: Sayed M. Derayea, et al.
Published: (2025-07-01)

Rapid Color Test Identification System for Screening of Counterfeit Fluoroquinolone
by: B. K. Singh, et al.
Published: (2009-01-01)